碧迪医疗
BDX175.220USD
-3.030-1.70%
交易中 （美东）报价延迟15分钟
50.22B总市值
33.52市盈率 TTM
关于 Becton Dickinson and Co 公司
碧迪医疗是一家全球医疗技术公司。该公司从事医疗机构、医生、生命科学研究人员、临床实验室等使用的各种医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。其 BD 医疗部门生产一系列医疗技术和设备，用于帮助改善各种环境中的医疗服务。BD 医疗部门由多个业务部门组成，包括药物输送解决方案、药物管理解决方案、高级监控和制药系统。其 BD 生命科学部门提供用于收集和运输诊断样本的产品，以及用于检测各种传染病、医疗相关感染和癌症的仪器和试剂系统。其 BD 介入部门提供血管、泌尿科、肿瘤科和外科专业产品。
公司简介
公司代码BDX
公司名称Becton Dickinson and Co
上市日期Sep 25, 1963
成立日期1906
CEOMr. Thomas E. Polen
员工数量74000
证券类型Ordinary Share
年结日Sep 25
公司地址One Becton Drive
城市FRANKLIN LAKES
上市交易所NYSE Consolidated
国家United States of America
邮编07417-1880
电话12018476800
网址https://www.bd.com/
公司代码BDX
上市日期Sep 25, 1963
成立日期1906
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
9.19K
+38.45%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.25K
+21.54%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Medication Delivery Solutions
1.12B
21.19%
Medication Management Solutions
811.00M
15.38%
Pharmaceutical Systems
575.00M
10.91%
Peripheral Intervention
481.00M
9.12%
Integrated Diagnostic Solutions
456.00M
8.65%
Other
1.83B
34.75%
地区USD
名称
营收
占比
United States
3.11B
58.93%
International
2.16B
41.05%
业务
地区
业务USD
名称
营收
占比
Medication Delivery Solutions
1.12B
21.19%
Medication Management Solutions
811.00M
15.38%
Pharmaceutical Systems
575.00M
10.91%
Peripheral Intervention
481.00M
9.12%
Integrated Diagnostic Solutions
456.00M
8.65%
Other
1.83B
34.75%
股东统计
更新时间: 7月24日 周四
更新时间: 7月24日 周四
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.88%
T. Rowe Price Investment Management, Inc.
4.39%
T. Rowe Price Associates, Inc.
3.80%
Other
70.50%
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.88%
T. Rowe Price Investment Management, Inc.
4.39%
T. Rowe Price Associates, Inc.
3.80%
Other
70.50%
股东类型
持股股东
占比
Investment Advisor
52.01%
Investment Advisor/Hedge Fund
29.01%
Hedge Fund
3.22%
Research Firm
2.93%
Pension Fund
2.77%
Bank and Trust
1.60%
Sovereign Wealth Fund
1.22%
Individual Investor
0.57%
Insurance Company
0.30%
Other
6.38%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
2852
268.57M
93.70%
-14.10M
2025Q1
2897
269.10M
93.89%
-12.90M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
2023Q1
2795
257.22M
90.56%
-8.75M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
32.31M
11.27%
+4.44M
+15.92%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.79M
5.16%
-22.91K
-0.15%
Mar 31, 2025
State Street Global Advisors (US)
13.99M
4.88%
-94.83K
-0.67%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
12.58M
4.39%
+448.64K
+3.70%
Mar 31, 2025
T. Rowe Price Associates, Inc.
10.89M
3.8%
-1.04M
-8.70%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.48M
2.26%
+127.97K
+2.01%
Mar 31, 2025
MFS Investment Management
6.11M
2.13%
+655.88K
+12.02%
Mar 31, 2025
First Eagle Investment Management, L.L.C.
5.52M
1.93%
+1.09M
+24.64%
Mar 31, 2025
Generation Investment Management LLP
5.30M
1.85%
-518.93K
-8.92%
Mar 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
4.96M
1.73%
-737.71K
-12.95%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
iShares U.S. Medical Devices ETF
4.36%
American Century Focused Large Cap Value ETF
3.16%
First Eagle Global Equity ETF
3.14%
T Rowe Price Capital Appreciation Equity ETF
3.11%
Franklin ClearBridge Enhanced Income ETF
2.93%
iShares Large Cap Value Active ETF
2.34%
Running Oak Efficient Growth ETF
1.9%
SPDR S&P Health Care Equipment ETF
1.8%
T Rowe Price Equity Income ETF
1.72%
First Trust Indxx Medical Devices ETF
1.61%
查看更多
iShares U.S. Medical Devices ETF
占比4.36%
American Century Focused Large Cap Value ETF
占比3.16%
First Eagle Global Equity ETF
占比3.14%
T Rowe Price Capital Appreciation Equity ETF
占比3.11%
Franklin ClearBridge Enhanced Income ETF
占比2.93%
iShares Large Cap Value Active ETF
占比2.34%
Running Oak Efficient Growth ETF
占比1.9%
SPDR S&P Health Care Equipment ETF
占比1.8%
T Rowe Price Equity Income ETF
占比1.72%
First Trust Indxx Medical Devices ETF
占比1.61%
分红派息
近5年累计派现
5.34B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
